SERUM INSTITUTE
COVID-19 Vaccine Booster Dose: DGCI Approves Market Authorisation of Serum Institute's Covovax as Precautionary Jab
Ebola Vaccine: DCGI Gives Nod to SII-Manufactured Sudan Virus Vaccine for Export to Uganda
Cyber Fraud in Maharashtra: Fraudsters Dupe Vaccine-Maker Serum Institute of India of Over Rs 1 Cr, Sends Messages in Name of CEO Adar Poonawalla; Investigation Underway
Man Seeks Rs 1,000 Crore Compensation Claiming Daughter’s Death Due to Covishield Side Effects; Notice Issued to Serum Institute, Bill Gates and Others
Serum Institute of India’s Vaccine to Treat Cervical Cancer Gets DCGI’s Nod, to Launch Later This Year
DCGI's EUA Nod to SII's Covovax For 12-17 Years Age Group; Adar Poonawalla Says Younger Age Groups to Follow Shortly
Covaxin Latest Update: Bharat Biotech's Partner Ocugen Seeks Approval of COVID-19 Vaccine in America for Children Below 18 Years
Covishield, Covaxin, Sputnik V Price Capped For Private Hospitals; Here’s How Much They Will Cost Now
COVID-19 Vaccination: 25 Crore Doses Of Covishield And 19 Crore Of Covaxin To Be Procured To Achieve Universalization Of Vaccination
COVID-19 Vaccination To Open For 60+ Age Group From March 1: How To Get The Vaccine If You Are Over 60 Or Over 45 With Co-Morbidities
Two Fires At Serum Institute Of India Compound In Pune, Five Dead; Covishield Vaccine Production Unaffected; PM Modi Offers Condolences
Delhi: Fire Breaks Out in a Building in ITO Area, 3 Fire Tenders at Spot to Douse Raging Flames
Google Trends